PharmaNet
10
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
40.0%
4 terminated/withdrawn out of 10 trials
60.0%
-26.5% vs industry average
40%
4 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Long-term Experience With Abatacept SC in Routine Clinical Practice
Role: collaborator
Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy
Role: collaborator
An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)
Role: collaborator
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Role: collaborator
Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects
Role: collaborator
A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels
Role: collaborator
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Role: collaborator
Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)
Role: lead
Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population
Role: collaborator
Pain Relief Investigation of NeuroModulation Therapy in Adult Humans
Role: collaborator
All 10 trials loaded